Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoon, J. W.
Right arrow Articles by Notkins, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoon, J. W.
Right arrow Articles by Notkins, A. L.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 27, Issue 7 778-781, Copyright © 1978 by American Diabetes Association

ARTICLES

Virus-induced diabetes mellitus. XI. Replication of coxsackie B3 virus in human pancreatic beta cell cultures

JW Yoon, T Onodera, AB Jenson and AL Notkins

The capacity of Coxsackie B3 virus to infect insulin-containing beta cells was studied in human pancreatic cell cultures. Antibody to Coxsackie B3 virus was labeled with fluorescein isothiocyanate, and antibody to insulin was labeled with rhodamine. By use of a double-label antibody technique, three populations of cells were identified: uninfected insulin-containing beta cells, which stained only with rhodamine-labeled anti-insulin antibody; Coxsackie-infected (noninsulin-containing) cells, which stained only with fluorescein-labeled anti-Coxsackie antibody; and Coxsackie-infected insulin-containing beta cells, which stained with both antibodies. Radioimmunoassay showed that intracellular immunoreactive insulin decreased rapidly beginning at 24 hours after infection, and the decrease in insulin roughly paralleled the increase in viral titer. It is concluded that, under in vitro conditions, human beta cells are susceptible to Coxsackie B3 virus.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
T. Kanno, K. Kim, K. Kono, K. M. Drescher, N. M. Chapman, and S. Tracy
Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
J. Virol., June 1, 2006; 80(11): 5637 - 5643.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Flodstrom, D. Tsai, C. Fine, A. Maday, and N. Sarvetnick
Diabetogenic Potential of Human Pathogens Uncovered in Experimentally Permissive {beta}-Cells
Diabetes, August 1, 2003; 52(8): 2025 - 2034.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W. Chehadeh, J. Kerr-Conte, F. Pattou, G. Alm, J. Lefebvre, P. Wattré, and D. Hober
Persistent Infection of Human Pancreatic Islets by Coxsackievirus B Is Associated with Alpha Interferon Synthesis in beta Cells
J. Virol., November 1, 2000; 74(21): 10153 - 10164.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Roivainen, S. Rasilainen, P. Ylipaasto, R. Nissinen, J. Ustinov, L. Bouwens, D. L. Eizirik, T. Hovi, and T. Otonkoski
Mechanisms of Coxsackievirus-Induced Damage to Human Pancreatic {beta}-Cells
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 432 - 440.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1978 by the American Diabetes Association.